Document:

exv10w2

 

EXHIBIT 10.2

AGREEMENT TO AMEND

     AGREEMENT dated May 30, 2006 among Sovereign Bancorp, Inc., a Pennsylvania corporation (the
“Corporation”), and Lawrence M. Thompson, Jr. (the “Executive”).

     WHEREAS, the Corporation entered into an Employment Agreement with Executive dated as of
September 25, 1997 (the “Employment Agreement”); and

     WHEREAS, the Corporation has entered into an Investment Agreement with Banco Santander Central
Hispano, S.A. dated October 24, 2005, and amended November, 22, 2005 (the “Investment Agreement”);
and

     WHEREAS, pursuant to the terms of the Investment Agreement, each of the Corporation and
Executive desires to amend the Employment Agreement to modify the definition of Change in Control
in certain respects.

     NOW, THEREFORE, in consideration of the foregoing and the mutual covenants set forth herein,
the parties hereto agree as follows:

     1. Amendment of Employment Agreement.

     Effective as of the date hereof, the following amendment to the Employment Agreement shall
become effective and the modifications to the Employment Agreement set forth herein shall be
incorporated into the terms of Employment Agreement as follows:

     (a) Section 5(b) shall be amended to read as follows:

     (b) As used in this Agreement, “Change in Control” means the first to occur of any of the
following events:

     (i) any “Person” (as such term is used in Sections 13(d) and 14(d) of the
Securities Exchange Act of 1934, as amended), except for any of SBI’s employee
benefit plans, or any entity holding SBI’s voting securities for, or pursuant to,
the terms of any such plan (or any trust forming a part thereof) (the “Benefit
Plan(s)”), is or becomes the beneficial owner, directly or indirectly, of SBI’s
securities representing 19.9% or more of the combined voting power of SBI’s then
outstanding securities, other than: (A) pursuant to a transaction excepted in Clause
(iii) or (iv); or (B) pursuant to a Buyer Acquisition Transaction (as defined in the
Investment Agreement (the “Investment Agreement”), between SBI and Banco Santander
Central Hispano, S.A., dated as of October 24, 2005, as amended as of November 22,
2005) effectuated in accordance with the terms of the Investment Agreement other
than a Buyer Acquisition Transaction contemplated in Sections 8.06 through 8.08 and
8.10 of the Investment Agreement;

     (ii) there occurs a contested proxy solicitation of SBI’s shareholders that
results in the contesting party obtaining the ability to vote securities

1

 

representing 19.9% or more of the combined voting power of SBI’s then outstanding
securities;

     (iii) a binding written agreement is executed (and, if legally required,
approved by SBI’s shareholders) providing for a sale, exchange, transfer or other
disposition of all or substantially all of the assets of SBI or of Sovereign Bank to
another entity, except to an entity controlled directly or indirectly by SBI;

     (iv) the shareholders of SBI approve a merger, consolidation, or other
reorganization of SBI, unless:

     (A) under the terms of the agreement approved by SBI’s shareholders
providing for such merger, consolidation or reorganization, the
shareholders of SBI immediately before such merger, consolidation or
reorganization, will own, directly or indirectly immediately following
such merger, consolidation or reorganization, at least 51% of the combined
voting power of the outstanding voting securities of SBI resulting from
such merger, consolidation or reorganization (the “Surviving Corporation”)
in substantially the same proportion as their ownership of the voting
securities immediately before such merger, consolidation or
reorganization;

     (B) under the terms of the agreement approved by SBI’s shareholders
providing for such merger, consolidation or reorganization, the
individuals who were members of the Board of Directors of SBI immediately
prior to the execution of such agreement will constitute at least 51% of
the members of the board of directors of the Surviving Corporation after
such merger, consolidation or reorganization; and

     (C) based on the terms of the agreement approved by SBI’s
shareholders providing for such merger, consolidation or reorganization,
no Person (other than (A) SBI or any Subsidiary of SBI, (B) any Benefit
Plan, (C) the Surviving Corporation or any Subsidiary of the Surviving
Corporation, or (D) any Person who, immediately prior to such merger,
consolidation or reorganization had beneficial ownership of 19.9% or more
of the then outstanding voting securities) will have beneficial ownership
of 19.9% or more of the combined voting power of the Surviving
Corporation’s then outstanding voting securities;

     (v) a plan of liquidation or dissolution of SBI, other than pursuant to
bankruptcy or insolvency laws, is adopted;

     (vi) during any period of two consecutive years, individuals, who at the
beginning of such period, constituted the Board of Directors of SBI cease for any
reason to constitute at least a majority of the Board of Directors of SBI unless the

2

 

election, or the nomination for election by SBI’s shareholders, of each new director
was approved by a vote of at least two-thirds of the directors then still in office
who were directors at the beginning of the period; or

     (vii) the occurrence of a Triggering Event within the meaning of the Second
Amended and Restated Rights Agreement, between SBI and Mellon Investor Services LLC,
as rights agent, dated as of January 19, 2005, as amended on October 24, 2005, and
as it may be further amended from time to time.

Notwithstanding Clause (i), a Change in Control shall not be deemed to have occurred
if a Person becomes the beneficial owner, directly or indirectly, of SBI’s
securities representing 19.9% or more of the combined voting power of SBI’s then
outstanding securities solely as a result of an acquisition by SBI of its voting
securities which, by reducing the number of shares outstanding, increases the
proportionate number of shares beneficially owned by such Person to 19.9% or more of
the combined voting power of SBI’s then outstanding securities; provided, however,
that if a Person becomes a beneficial owner of 19.9% or more of the combined voting
power of SBI’s then outstanding securities by reason of share purchases by SBI and
shall, after such share purchases by SBI, become the beneficial owner, directly or
indirectly, of any additional voting securities of SBI (other than as a result of a
stock split, stock dividend or similar transaction), then a Change in Control of SBI
shall be deemed to have occurred with respect to such Person under Clause (a). In
no event shall a Change in Control of SBI be deemed to occur under Clause (a) with
respect to Benefit Plans.

     2. Effectiveness of the Terms of this Agreement.

     (a) Operative Effect Dependent on Closing of Investment Agreement. The operative effect of
this Agreement is subject to the occurrence of the Closing (as such term is defined in the
Investment Agreement). If the Closing does not occur, this amendment to the Employment Agreement
shall be null and void ab initio.

     (b) Binding on Executive. Notwithstanding anything to the contrary, Executive’s agreements
hereunder are binding, subject only to the occurrence of the Closing, and Executive has no right to
revoke, rescind or otherwise terminate or modify Executive’s agreements hereunder.

     3. Applicable Law.

     This amendment to the Employment Agreement shall be governed by and construed in accordance
with the domestic laws (but not the law of conflict of laws) of the Commonwealth of Pennsylvania.

     4. Representations and Warranties.

     The parties hereto represent and warrant to each other that they have carefully read this
amendment to the Employment Agreement and consulted with respect thereto with their respective
counsel, and that each of them fully understands the content of this amendment to the

3

 

Employment Agreement and its legal effect. Each party hereto also represents and warrants
that this amendment to the Employment Agreement is a legal, valid and binding obligation of such
party which is enforceable against such party in accordance with its terms.

     5. Successors and Assigns.

     This amendment to the Employment Agreement shall be binding upon, inure to the benefit of and
be enforceable by the parties hereto and their respective heirs, legal representatives, successors
and assigns. The Corporation shall require any successor (whether direct, indirect, by purchase,
merger, consolidation or otherwise) to all or substantially all of the business or assets of the
Corporation to expressly assume and agree to perform this amendment to the Employment Agreement, in
the same manner and to the same extent that the Corporation would be required to perform it if no
such succession had taken place, unless the provisions hereof will be binding upon such successor
by operation of law.

4

 

     IN WITNESS WHEREOF, the parties have executed this amendment to the Employment Agreement
effective as of the 30th day of May, 2006.

	 	 	 	 	 
	 	SOVEREIGN BANCORP, INC.

 	 
	 	/s/  Jay S. Sidhu
 	 
	 	By: Jay S. Sidhu 	 
	 	Title:  	President and Chief Executive Officer 	 
	 
	 	EXECUTIVE

 	 
	 	/s/  Lawrence M. Thompson, Jr.
 	 
	 	Lawrence M. Thompson, Jr. 	 
	 	 	 
	 

5exv10w1

 

Exhibit 10.1

EMPLOYMENT AGREEMENT

          EMPLOYMENT AGREEMENT (this “Agreement”), dated as of November 10, 2006, by and between PAR
PHARMACEUTICAL COMPANIES, INC., and PAR PHARMACEUTICAL, INC., each a Delaware corporation
(collectively, “Par” or “Employer”), and PATRICK LePORE (“Executive”).

RECITALS

     A. WHEREAS, Employer wishes to employ Executive in the capacity of President and Chief
Executive Officer of Par Pharmaceutical Companies, Inc., and as President and Chief Executive
Officer of Par Pharmaceutical, Inc., and Executive desires to provide services in these capacities;
and

     B. WHEREAS, Employer and Executive desire to formalize the terms and conditions of Executive’s
employment with Employer.

          In consideration of the mutual promises herein contained, the parties hereto hereby agree as
follows:

OPERATIVE PROVISIONS

     1. Employment.

          1.1 General. Par hereby employs Executive effective September 27, 2006 (the
“Effective Date”), in the capacity of Chief Executive Officer and President of Par, at the
compensation rate and benefits set forth in Section 2 hereof, for the Employment Term (as defined
in Section 3.1 hereof). Executive hereby accepts such employment, subject to the terms and
conditions herein contained. In all such capacities, Executive shall perform and carry out such
duties and responsibilities as may be assigned to him from time to time by the Board of Directors
(the “Board”) reasonably consistent with Executive’s position and this Agreement, and shall report
to the Board.

          1.2 Time Devoted to Position. Executive, during the Employment Term, shall devote
substantially all of his business time, attention and skills to the business and affairs of
Employer.

          1.3 Certifications. Whenever the Chief Executive Officer and/or Chief Financial
Officer of Employer are required by law, rule or regulation, or requested by any governmental
authority or by Par’s auditors, to provide certifications with respect to Par’s financial
statements or filings with the Securities and Exchange Commission or any other governmental
authority, Executive shall sign such certifications as may be reasonably requested by Employer,
with such exceptions as Executive deems necessary to make such certifications accurate and not
misleading.

 

 

     2. Compensation and Benefits.

          2.1 Salary. At all times Executive is employed hereunder, Employer shall pay to
Executive, and Executive shall accept, as full compensation for any and all services rendered and
to be rendered by him during such period to Employer in all capacities, including, but not limited
to, all services that may be rendered by him to any of Employer’s existing subsidiaries, entities
and organizations hereafter formed, organized or acquired by Employer, directly or indirectly
(each, a “Subsidiary” and collectively, the “Subsidiaries”), the following: (i) a base salary at
the annual rate of six hundred and twenty thousand and four hundred dollars ($620,400.00) (the
“Base Salary”); (ii) any additional bonus; and (iii) the benefits set forth in Sections 2.2, 2.3,
and 2.4 hereof. The Base Salary shall be payable in accordance with the regular payroll practices
of Employer applicable to senior executives, less such deductions as shall be required to be
withheld by applicable law and regulations or otherwise.

          2.2 Bonus. Subject to Section 3.3 hereof, Executive may be considered for a bonus
during the Employment Term in such amount (if any) as determined by the Board based on such
performance criteria as it deems appropriate, including, without limitation, Executive’s
performance and Employer’s earnings, financial condition, rate of return on equity, and compliance
with regulatory requirements. Notwithstanding the preceding, the payment, timing, and amount of
any bonus are solely within the discretion of the Board.

          2.3 Equity Awards. Executive shall be entitled to participate in long-term incentive
plans commensurate with his title and position, including, without limitation, restricted stock,
stock option, and similar equity plans of Employer as may be offered from time to time. In
connection herewith, Executive has been granted thirty five thousand (35,000) shares of restricted
stock of Par, and options to purchase one hundred twenty thousand (120,000) shares of common stock
of Par, on the terms and conditions set forth in the 2004 Performance Equity Plan, as amended (the
“2004 Plan”) and Executive’s Stock Option Agreement and Award Agreement. Notwithstanding the terms
of any applicable plan or stock option agreement, in the event that Executive and Employer enter
into another agreement for Executive’s employment after the Employment Term has expired, all
restricted stock and stock options shall vest in their normal course subject to any related terms
and conditions set forth in any subsequent agreement between the parties. However, if Executive is
separated from Employer, for any reason whatsoever, prior to the last day of the Employment Term,
all restricted stock and options granted to Executive shall be cancelled. If Executive remains
employed for the entire Employment Term, but Executive and Employer do not enter into a new
agreement for employment of Executive upon or prior to expiration of the Employment Term, all
restricted stock shall vest on the day following the expiration of the Employment Term and all
stock options shall be cancelled. Except as modified by the terms of this Section 2.3, all
long-term incentive awards and grants pursuant to this paragraph shall be subject to the terms and
conditions set forth in the 2004 Plan and the Stock Option and Award Agreements relating to such
options and shares.

-2-

 

          2.4 Executive Benefits.

               2.4.1 Expenses. Employer shall promptly reimburse Executive for expenses he
reasonably incurs in connection with the performance of his duties (including business travel and
entertainment expenses) hereunder, all in accordance with Employer’s policies with respect thereto
as in effect from time to time.

               2.4.2 Employer Plans. Executive shall be entitled to participate in such employee
benefit and welfare plans and programs as Employer may from time to time generally offer or provide
to executive officers of Employer or its Subsidiaries, including, but not limited to, participation
in life insurance, health and accident, medical plans and programs, and profit sharing and
retirement plans.

               2.4.3 Vacation. Executive shall initially be entitled to four (4) weeks of paid
vacation per calendar year, pro-rated for any partial year during the Employment Term.

               2.4.4 Automobile. Employer shall provide Executive with an automobile cash allowance
in the amount of one thousand and fifty dollars ($1,050.00) (gross) per month.

               2.4.5 Life Insurance. Employer shall obtain (provided, that Executive qualifies on a
non-rated basis) a term life insurance policy, the premiums of which shall be borne by Employer and
the death benefits of which shall be payable to Executive’s estate, or as otherwise directed by
Executive, in the amount of three million dollars ($3,000,000.00) throughout the Employment Term.

     3. Employment Term; Termination.

          3.1 Employment Term. Executive’s employment hereunder shall commence on the Effective
Date (as defined in Section 1.1 hereof) and, except as otherwise provided in Section 3.2 hereof,
shall continue until the first (1st) anniversary of the Effective Date (the “Employment Term”).
Executive’s employment shall terminate on the first (1st) anniversary of the Effective Date (the
end of the Employment Term). With the exception of the terms that specifically survive this
agreement (such as the terms set forth in Section 4 hereof), the terms of this Agreement that
operate to employ Executive shall not be effective after the first (1st) anniversary of the
Effective Date, and under no circumstances shall Executive be employed pursuant to any term of this
Agreement beyond the first (1st) anniversary of the Effective Date. Should Employer and Executive
mutually agree that Executive will become employed by Employer for another term, a new employment
agreement must be entered into by the parties. Upon termination of the Employment Term pursuant to
this Section 3.1, or pursuant to Sections 3.2.1 through 3.2.6 hereof, inclusive, Executive shall be
released from any duties hereunder (except as set forth in Section 4 hereof) and the obligations of
Employer to Executive shall be as set forth in Section 3.3 hereof only.

-3-

 

          3.2 Events of Termination. The Employment Term shall terminate upon the occurrence of
any one or more of the following events:

               3.2.1 Death. In the event of Executive’s death, the Employment Term shall terminate
on the date of his death.

               3.2.2 Without Cause By Executive. Executive may terminate the Employment Term at any
time during such Employment Term for any reason whatsoever by giving a Notice of Termination to
Employer. The Date of Termination (as defined in Section 3.4.2 herein) pursuant to this Section
3.2.2 shall be thirty (30) days after the Notice of Termination is given or such shorter period as
Employer shall determine, in Employer’s sole discretion, provided that Employer shall pay to
Executive that amount of the Base Salary that would have been earned between the 30-day period and
such shorter period.

               3.2.3 Disability. In the event of Executive’s Disability (as hereinafter defined),
Employer may, at its option, terminate the Employment Term by giving a Notice of Termination to
Executive. The Notice of Termination shall specify the Date of Termination, which date shall not
be earlier than thirty (30) days after the Notice of Termination is given. For purposes of this
Agreement, “Disability” means disability as defined in any long-term disability insurance policy
provided by Employer and insuring Executive, or, in the absence of any such policy, the inability
of Executive for one hundred eighty (180) days in any twelve (12) month period to substantially
perform his duties hereunder as a result of a physical or mental illness, all as determined in good
faith by the Board.

               3.2.4 Cause. Employer may, at its option, terminate the Employment Term for “Cause”
based on objective factors determined in good faith by a majority of the Board as set forth in a
Notice of Termination to Executive specifying the reasons for termination and the failure of
Executive to cure same within ten (10) days after Employer shall have given the Notice of
Termination; provided, however, that in the event the Board in good faith
determines that the underlying reasons giving rise to such determination cannot be cured, then the
ten (10) day period shall not apply and the Date of Termination shall be the date the Notice of
Termination is given. For purposes of this Agreement, “Cause” shall mean (i) Executive’s
conviction of, guilty or no contest plea to, or confession of guilt to, a felony or other crime
involving moral turpitude; (ii) an act or omission by Executive in connection with his employment
that constitutes fraud, criminal misconduct, breach of fiduciary duty, dishonesty, gross
negligence, malfeasance, willful misconduct or other conduct that is materially harmful or
detrimental to Employer; (iii) a material breach by Executive of this Agreement; (iv) continuing
failure to perform such duties as are assigned to Executive by Employer in accordance with this
Agreement, other than a failure resulting from a disability as defined in Section 3.2.3; (v)
Executive’s knowingly taking any action on behalf of Employer or any of its Subsidiaries or
affiliates without appropriate authority to take such action; (vi) Executive’s knowingly taking any
action in conflict of interest with Employer or any of its Subsidiaries or affiliates given
Executive’s position with Employer; and/or (vii) the commission of an act of personal dishonesty by
Executive in connection with Employer that involves personal profit.

-4-

 

               3.2.5 Without Cause By Employer. Employer may, at its option, terminate the
Employment Term for any reason or no reason whatsoever (other than for the reasons set forth
elsewhere in this Section 3.2) by giving a Notice of Termination to Executive. The Notice of
Termination shall specify the Date of Termination, which date shall not be earlier than thirty (30)
days after the Notice of Termination is given or such shorter period as Employer shall determine,
in Employer’s sole discretion, provided that Employer shall pay to Executive that amount of the
Base Salary that would have been earned between the 30-day period and such shorter period.

               3.2.6 Employer’s Material Breach. Executive may, at his option, terminate the
Employment Term upon Employer’s material breach of this Agreement and the continuation of such
breach for more than ten (10) days after written demand for cure of such breach is given to
Employer by Executive (which demand shall identify the manner in which Employer has materially
breached this Agreement). Employer’s material breach of this Agreement shall mean (i) the failure
of Employer to make any payment that it is required to make hereunder to Executive when such
payment is due or within two (2) business days thereafter; (ii) the assignment to Executive,
without Executive’s express written consent, of duties inconsistent with his position,
responsibilities and status with Employer, or a change in Executive’s reporting responsibilities,
titles or offices or any plan, act, scheme or design to constructively terminate the Executive, or
any removal of Executive from his positions with Employer, except in connection with the
termination of the Employment Term by Employer for cause, without cause, for disability, as a
result of Executive’s death or voluntary resignation, or by Executive other than pursuant to this
Section 3.2.6; (iii) a reduction by Employer in Executive’s Base Salary; or (iv) a permanent
reassignment of Executive’s primary work location, without the consent of Executive, to a location
more than thirty five (35) miles from Employer’s executive offices in Woodcliff Lake, New Jersey.

          3.3 Obligations of Employer Following Termination of the Employment Term. In the
event that the Employment Term is terminated by Employer or Executive for any reason prior to its
expiration, Employer shall pay to Executive, in a single lump-sum, an amount equal to any unpaid
but earned Base Salary through the Date of Termination. Executive shall be entitled to no other
separation pay other than as described in 3.3.1 below. Executive shall be entitled to no bonuses,
and all benefits and allowances provided for herein shall terminate as of the Date of Termination.

               3.3.1 Termination Without Cause by Employer or by Executive for Employer’s Material
Breach. In the event that the Employment Term is terminated without cause by Employer as set
forth in Section 3.2.5 herein, or by Executive for Employer’s material breach as set forth in
Section 3.2.6 hereof, Employer shall pay Executive his salary as set forth in Section 2.1 hereof
for the remainder of the Employment Term. Executive shall be entitled to no other compensation or
benefits during the remainder of the Employment Term. In the event that Executive, after
Employer’s termination without cause or Executive’s termination for employer’s material breach,
directly or indirectly provides any services (whether in the management, sales, marketing, public
relations, finance, research, development, general office,
administrative or

-5-

 

other areas) as an employee, agent, stockholder, officer, director, consultant, advisor,
investor or other representative of Employer’s competitors in the branded or generic pharmaceutical
industry in any state or country in which Employer does or seeks to do business as defined in
Section 4.4 hereof, such continued salary payments as described in this Section 3.3.1 shall
immediately cease and Employer shall have no further obligations to pay salary under this Section.

          3.4 Definitions.

               3.4.1 “Notice of Termination” Defined. “Notice of Termination” means a written notice
that indicates the specific termination provision relied upon by Employer or Executive and, except
in the case of termination pursuant to Sections 3.2.1, 3.2.2 or 3.2.5 hereof, that sets forth in
reasonable detail the facts and circumstances claimed to provide a basis for termination of the
Employment Term under the termination provision so indicated.

               3.4.2 “Date of Termination” Defined. “Date of Termination” means either such date as
the Employment Term is expired if not renewed, or such date as the Employment Term is terminated,
in accordance with, respectively, Sections 3.1 or 3.2 hereof.

     4. Confidentiality/ Non-Solicitation/Non-Compete.

          4.1 “Confidential Information” Defined. “Confidential Information” means any and all
information (oral or written) relating to Employer or any of its Subsidiaries or any person
controlling, controlled by, or under common control with Employer or any of its Subsidiaries or any
of their respective activities, including, but not limited to, information relating to:
technology; research, test procedures and results; machinery and equipment; manufacturing
processes; financial information; products; identity and description of materials and services
used; purchasing; costs; pricing; customers and prospects; advertising, promotion and marketing;
and selling, servicing and information pertaining to any governmental investigation, except such
information which becomes public, other than as a result of a breach of the provisions of Section
4.2 hereof. Without limiting the foregoing, Confidential Information shall also include all
information related to products targeted for development by Employer and/or its Subsidiaries,
subjects of research and development, projected launch dates, the United States Food and Drug
Administration (FDA) protocols, projected dates for regulatory filings, consumer studies, market
research, clinical research, business plans, content of the New Product Planning Committee
meetings, planned expenditures, profit margins, strategic evaluation plans and initiatives, and
those commissioned by Employer through outside vendors or consultants, and the content of all
business and strategic planning conducted with or through third parties. Executive’s obligation
not to disclose Confidential Information shall be as set forth in Section 4.2 of this Agreement,
and shall include his obligation not to place himself in any business position in which use or
disclosure of Employer’s confidences will be likely, expected or inevitable, for Executive’s own
benefit or the benefit of any other person or entity.

-6-

 

          4.2 Non-disclosure of Confidential Information. Executive shall not at any time
(other than as may be required or appropriate in connection with the performance by him of his
duties hereunder), directly or indirectly, use, communicate, disclose or disseminate any
Confidential Information in any manner whatsoever for the benefit of any person or entity other
than Employer (except as may be required under legal process by subpoena or other court order).

          4.3 Non-Solicitation. Executive shall not, while employed by Employer and for a
period of one (1) year following the Date of Termination, directly or indirectly hire, offer to
hire, entice away or in any other manner persuade or attempt to persuade any officer, employee,
agent, lessor, lessee, licensor, licensee, customer, prospective customer or supplier of Employer
or any of its Subsidiaries to discontinue or alter his/her or its relationship with Employer or any
of its Subsidiaries.

          4.4 Non-Competition. Executive shall not, while employed by Employer and for a period
equal to one (1) year following the Date of Termination, directly or indirectly provide any
services (whether in the management, sales, marketing, public relations, finance, research,
development, general office, administrative or other areas) as an employee, agent, stockholder,
officer, director, consultant, advisor, investor or other representative of Employer’s competitors
in the branded or generic pharmaceutical industry in any state or country in which Employer does or
seeks to do business. Employer’s competitors include any entity, individual or affiliate of such
company or individual that develops, sells, markets or distributes any products that compete with
or are the same or similar to those of Employer.

          However, the restrictions of this paragraph 4.4 shall not apply if the Employment Term is
terminated by Employer pursuant to Section 3.2.5 hereof or by Executive properly pursuant to 3.2.6
hereof; nor shall this paragraph prohibit Executive from being a passive owner of not more than one
percent (1%) of any publicly-traded class of capital stock of any entity engaged in a competing
business.

          4.5 Injunctive Relief. The parties hereby acknowledge and agree that (a) the type,
scope and periods of restrictions imposed in paragraph 4 are necessary, fair and reasonable to
protect Employer’s legitimate business interests and to prevent the inevitable disclosure of
Employer’s Confidential Information; (b) Employer will be irreparably injured in the event of a
breach by Executive of any of his obligations under this Section 4; (c) monetary damages will not
be an adequate remedy for any such breach; (d) Employer will be entitled to injunctive relief, in
addition to any other remedy which it may have, in the event of any such breach; and (e) the
existence of any claims that Executive may have against Employer, whether under this Agreement or
otherwise, will not be a defense to the enforcement by Employer of any of its rights under this
Section 4.

          4.6 Non-exclusivity and Survival. The covenants of Executive contained in this
Section 4 are in addition to, and not in lieu of, any obligations that Executive may have with
respect to the subject matter hereof, whether by contract, as a matter of law or otherwise, and
such covenants and their enforceability shall survive any termination of the Employment Term by
either party and any investigation made with respect to the breach thereof by Employer at any time.

-7-

 

     5. Miscellaneous Provisions.

          5.1 Severability. If, in any jurisdiction, any term or provision hereof is determined
to be invalid or unenforceable, (a) the remaining terms and provisions hereof shall be unimpaired;
(b) any such invalidity or unenforceability in any jurisdiction shall not invalidate or render
unenforceable such provision in any other jurisdiction; and (c) the invalid or unenforceable term
or provision shall, for purposes of such jurisdiction, be deemed replaced by a term or provision
that is valid and enforceable and that comes closest to expressing the intention of the invalid or
unenforceable term or provision.

          5.2 Execution in Counterparts. This Agreement may be executed in one or more
counterparts, and by the different parties hereto in separate counterparts, each of which shall be
deemed to be an original but all of which taken together shall constitute one and the same
agreement (and all signatures need not appear on any one counterpart), and this Agreement shall
become effective when one or more counterparts has been signed by each of the parties hereto and
delivered to each of the other parties hereto.

          5.3 Notices. All notices, requests, demands and other communications hereunder shall
be in writing and shall be deemed duly given upon receipt when delivered by hand, overnight
delivery or telecopy (with confirmed delivery), or three (3) business days after posting, when
delivered by registered or certified mail or private courier service, postage prepaid, return
receipt requested, as follows:

     If to Employer, to:

Par Pharmaceutical Companies, Inc.

300 Tice Boulevard

Woodcliff Lake, New Jersey 07677

Attention: Chairman

Telecopy No. (201) 802-4180

     Copy to:

Christine A. Amalfe, Esq.

Gibbons, Del Deo, Dolan, Griffinger & Vecchione, P.C.

One Riverfront Plaza

Newark, New Jersey 07102-5496

Telecopy No. (973) 639-6230

     If to Executive, to:

Patrick LePore

c/o Par Pharmaceutical Companies, Inc.

300 Tice Boulevard

Woodcliff Lake, New Jersey 07677

or to such other address(es) as a party hereto shall have designated by like notice to the other
parties hereto.

-8-

 

          5.4 Amendment. No provision of this Agreement may be modified, amended, waived or
discharged in any manner except by a written instrument executed by both Employer and Executive.

          5.5 Entire Agreement. This Agreement constitutes the entire agreement of the parties
hereto with respect to the subject matter hereof, and supersedes all prior agreements and
understandings of the parties hereto, oral or written.

          5.6 Applicable Law. This Agreement shall be governed by and construed in accordance
with the laws of the State of New Jersey applicable to contracts made and to be wholly performed
therein.

          5.7 Headings. The headings contained herein are for the sole purpose of convenience
of reference, and shall not in any way limit or affect the meaning or interpretation of any of the
terms or provisions of this Agreement.

          5.8 Binding Effect; Successors and Assigns. Executive may not delegate any of his
duties or assign his rights hereunder. This Agreement shall inure to the benefit of, and be
binding upon, the parties hereto and their respective heirs, legal representatives, successors and
permitted assigns. Employer shall require any successor (whether direct or indirect and whether by
purchase, merger, consolidation or otherwise) to all or substantially all of the business and/or
assets of Employer, by an agreement in form and substance reasonably satisfactory to Executive, to
expressly assume and agree to perform this Agreement in the same manner and to the same extent that
Employer would be required to perform if no such succession had taken place.

          5.9 Waiver, etc. The failure of either of the parties hereto to at any time enforce
any of the provisions of this Agreement shall not be deemed or construed to be a waiver of any such
provision, nor to in any way affect the validity of this Agreement or any provision hereof or the
right of either of the parties hereto thereafter to enforce each and every provision of this
Agreement. No waiver of any breach of any of the provisions of this Agreement shall be effective
unless set forth in a written instrument executed by the party against whom or which enforcement of
such waiver is sought, and no waiver of any such breach shall be construed or deemed to be a waiver
of any other or subsequent breach.

          5.10 Capacity, etc. Executive and Employer hereby represent and warrant to the other
that, as the case may be: (a) he or it has full power, authority and capacity to execute and
deliver this Agreement, and to perform his or its obligations hereunder; (b) such execution,
delivery and performance shall not (and with the giving of notice or lapse of time or both would
not) result in the breach of any agreements or other obligations to which he or it is a party or he
or it is otherwise bound; and (c) this Agreement is his or its valid and binding obligation in
accordance with its terms.

          5.11 Enforcement; Jurisdiction. If any party institutes legal action to enforce or
interpret the terms and conditions of this Agreement, the prevailing party shall be awarded
reasonable attorneys’ fees at all trial and appellate levels, and the expenses and costs incurred
by

-9-

 

such prevailing party in connection therewith. Any legal action, suit or proceeding, in
equity or at law, arising out of or relating to this Agreement shall be instituted exclusively in
the State or Federal courts located in the State of New Jersey, and each party agrees not to
assert, by way of motion, as a defense or otherwise, in any such action, suit or proceeding, any
claim that such party is not subject personally to the jurisdiction of any such court, that the
action, suit or proceeding is brought in an inconvenient forum, that the venue of the action, suit
or proceeding is improper or should be transferred, or that this Agreement or the subject matter
hereof may not be enforced in or by any such court. Each party further irrevocably submits to the
jurisdiction of any such court in any such action, suit or proceeding. Any and all service of
process and any other notice in any such action, suit or proceeding shall be effective against any
party if given personally or by registered or certified mail, return receipt requested or by any
other means of mail that requires a signed receipt, postage prepaid, mailed to such party as herein
provided. Nothing herein contained shall be deemed to affect or limit the right of any party to
serve process in any other manner permitted by applicable law.

          5.12 Arbitration.

               (a) Any dispute under Section 3 hereof, including, but not limited to, the determination by
the Board of a termination for Cause pursuant to Section 3.2.4 hereof, or in respect of the breach
thereof shall be settled by arbitration in the State of New Jersey. The arbitration shall be
accomplished in the following manner. Either party may serve upon the other party written demand
that the dispute, specifying the nature thereof, shall be submitted to arbitration. Within ten
(10) days after such demand is given in accordance with Section 5.3 hereof, each of the parties
shall designate an arbitrator and provide written notice of such appointment upon the other party.
If either party fails within the specified time to appoint such arbitrator, the other party shall
be entitled to appoint both arbitrators. The two (2) arbitrators so appointed shall appoint a
third arbitrator. If the two (2) arbitrators appointed fail to agree upon a third arbitrator
within ten (10) days after their appointment, then an application may be made by either party
hereto, upon written notice to the other party, to the American Arbitration Association (the
“AAA”), or any successor thereto, or if the AAA or its successor fails to appoint a third
arbitrator within ten (10) days after such request, then either party may apply, with written
notice to the other, to the Superior Court of New Jersey, Bergen County, for the appointment of a
third arbitrator, and any such appointment so made shall be binding upon both parties hereto.

               (b) The decision of the arbitrators shall be final and binding upon the parties. The party
against whom the award is rendered (the “non-prevailing party”) shall pay all fees and expenses
incurred by the prevailing party in connection with the arbitration (including fees and
disbursements of the prevailing party’s counsel), as well as the expenses of the arbitration
proceeding. The arbitrators shall determine in their decision and award which of the parties is
the prevailing party, which is the non-prevailing party, the amount of the fees and expenses of the
prevailing party and the amount of the arbitration expenses. The arbitration shall be conducted,
to the extent consistent with this Section 5.12, in accordance with the then prevailing rules of
commercial arbitration of the AAA or its successor. The arbitrators shall have the right to retain
and consult experts and competent authorities skilled in the matters
under

-10-

 

arbitration, but all consultations shall be made in the presence of both parties, who shall
have the full right to cross-examine the experts and authorities. The arbitrators shall render
their award, upon the concurrence of at least two of their number, not later than thirty (30) days
after the appointment of the third arbitrator. The decision and award shall be in writing, and
counterpart copies shall be delivered to each of the parties. In rendering an award, the
arbitrators shall have no power to modify any of the provisions of this Agreement, and the
jurisdiction of the arbitrators is expressly limited accordingly. Judgment may be entered on the
award of the arbitrators and may be enforced in any court having jurisdiction.

          IN WITNESS WHEREOF, this Agreement has been executed and delivered by the parties hereto as of
the date first above written.

	 	 	 	 	 
	 	PAR PHARMACEUTICAL COMPANIES, INC.

 	 
	 	By:  	/s/ Peter S. Knight
 	 
	 	 	Name:  	Peter S. Knight 	 
	 	 	Title:  	Chairperson of the Compensation Committee 	 
	 
	 	PAR PHARMACEUTICAL, INC.

 	 
	 	By:  	/s/ Gerard A. Martino
 	 
	 	 	Name:  	Gerard A. Martino 	 
	 	 	Title:  	Executive Vice President and Chief Financial Officer 	 
	 
	 	EXECUTIVE

 	 
	 	/s/ Patrick G. LePore
 	 
	 	Patrick G. LePore 	 
	 	 	 
	 

-11-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00115-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00115-of-00352.parquet"}]]